Sex differences in in vivo biomarkers of neurodegenerative dementia
Elijah Mak, Kejal Kantarci, Zoe Arvanitakis · 2025
Read Sex differences in in vivo biomarkers of neurodegenerative dementia by Elijah Mak, Kejal Kantarci, Zoe Arvanitakis (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12722451.txt.
Description
Elijah Mak, Kejal Kantarci, and Zoe Arvanitakis review, in a 2025 paper, sex differences in measurable signs of two common dementias. Alzheimer's disease and dementia with Lewy bodies differ between men and women in symptoms, frequency, and course. The biology underneath those gaps is poorly understood.
The authors searched the literature from 2000 to May 2025 for imaging and body-fluid marker studies. Their goal was to gather what living-patient markers reveal about how sex shapes each disease. Such markers can expose mechanisms that symptoms alone cannot. The synthesis aims to guide future research and more precise medicine. Treating sex as a real variable, not noise, is the paper's core plea.
Catalog record
| CREATOR | Elijah Mak, Kejal Kantarci, Zoe Arvanitakis |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |